IC
GOSS icon

IEQ Capital’s Gossamer Bio GOSS Stock Holding History

IEQ Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.3K Buy
591,254
+197,515
+50% +$55.1K ﹤0.01% 1945
2026
Q1 		$129K Buy
393,739
+382,528
+3,412% +$601K ﹤0.01% 1769
2025
Q4 		$34.8K Buy
+11,211
New +$32K ﹤0.01% 1818

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

IEQ Capital's GOSS Position: Q2 2026 in Review

IEQ Capital increased its Gossamer Bio (GOSS) stake by 50% in Q2 2026, buying an estimated $55.1K and bringing the position to 591,254 shares worth $97.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

IEQ Capital first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $129K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • IEQ Capital held 591,254 shares of Gossamer Bio worth $97.3K as of Q2 2026.
  • IEQ Capital bought 197,515 Gossamer Bio shares in Q2 2026, an estimated $55.1K.
  • Gossamer Bio made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1945 holding.
  • IEQ Capital first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • IEQ Capital's Gossamer Bio position peaked at $129K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.